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Editorial
The impact of Clinical Governance on Continuing Medical
Education and Continuing Professional Development
The Government's commitment to clinical
governance has been established in the White
Paper entitled "A First Class Service: Quality in
the new NHS". There are several definitions of
clinical governance but the simplest I have seen
isinthepaperonClinicalGovernanceinNorthern
Ireland "Corporate Accountability for clinical
performance". In Northern Ireland we are being
allowed to lag behind the introduction ofclinical
governanceinEnglandandWaleswhichoccurred
on 1st April, 1999.
The British Association of Medical Managers
has produced a paper on Clinical Governance in
which it highlights the very important role of
Continuing Medical Education (CME) and
Continuing Professional Development (CPD) in
assuring the quality of medical care. The GMC
has just announced that it intends to have five-
yearly reviews of specialists' continuing
competence to practise but it has not made clear
how this will be achieved. The Royal Colleges
haveforsomeyearspastbeenrecordingtheCME
activities oftheir fellows and members but none
has made any serious impact on the ability of
non-compliant practitioners to continue to
practise. Questions have been raised about the
currentsystemof"clocking"upthehourswithno
assessment as to their effectiveness.
There have been conflicts between general
practice and hospital staffin view ofthe fact that
a lecturer (often a hospital specialist) may get no
recompense but the listener (if a general
practitioner)canreceiveadditionalremuneration.
Methods of keeping up to date are protean;
personal reading, attendance at grand rounds,
clinical presentations, journal clubs, standard
setting and audit meetings, lectures, local
meetings of specialist societies, college based
educational activity atbothregional andnational
level, national and international conferences,
distance based learning, videoconferencing and
theinternet. Forabusypractitionertoattend such
meetings takes him away from the bedside,
outpatient clinic and operating theatre or
procedure room. Participation in education can
lead to clinical activity and may add to waiting
lists. Thereisalsoafinancialcosttosuchactivity.
For a National Health Service consultant on
National Terms and Conditions ofService, there
isanallowanceforleaveforstudyandprofessional
development of30days in any three-yearperiod,
withpayandexpenses. TheDepartmentofHealth,
both at national and regional level, accepts that
"all reasonable expenses" associated with an
approvedperiodofstudy-leave shouldbefunded.
The British Medical Association have recently
beensuccessfulinsupporting members whohave
not been reimbursed.
In the context of business management which
pervades ourcurrenthealth service, itis accepted
that the money for CME must come from
somewhere. The Department of Health in its
guidance on contracting has stated that CME/
CPDisa"quality"issueandassuchisalegitimate
additonal price which can be charged to
commissioners. Thecommissioners fortheirpart
accept this principle but state they have to live
within tightly constrained budgets and that, if
more oftheir funding goes for CME/CPD, there
will be less available for treating patients. The
Government has a political objective to reduce
waiting lists and wishes to see any additional
funding they are providing going directly to
increased activity.
Wehaveaparticularproblemonoursmallisland,
namely the high cost of travel to meetings. A
survey in 1995 by theNICSC gave firmevidence
that hospital trusts were not reimbursing
consultantswiththefullcostofattendingnational
and international conferences. There was
considerable reliance on the pharmaceutical
industry to attain CME 'points' and questions of
probity are obvious.
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Some trusts have adopted a system of a "ring-
fenced" allocation per head of consultant and if
any of this funding remains unused it can be
carried over to the next financial year.
The time is right for the Government adequately
to fund the CME/CDP activities of career-grade
hospitalstaff. (Thisshouldincludepart-timestaff.
A doctor who works half time must not be half
trained). In view ofthe travel distance involved,
the costs of courses, and the rising cost of hotel
accommodation, I suggest that more realistic
funding might be achieved by the provision of
funding of £100 per CME point obtained for
coursesoutsideNorthernIrelandandalessersum
forlocal courses depending onthedistance ofthe
Trust from Belfast.
AILBE BEIRNE,
Chairman, Medical Staff at Altnagelvin Area
Hospital. Former Chairman, Northern Ireland
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Why the NHS should fund
infertility services
One in six couples is infertile (Lower, 1993). Of
these, in Northern Ireland, approximately 1400
make use of assisted reproductive technologies
annually. CurrentlyinNorthernIreland,nopublic
fundingisavailableforinvitrofertilisation (IVF)
or intracytoplasmic sperm injection (ICSI),
(College of Health Report, 1997/8). Treatment,
therefore, depends solely on the couple's ability
to contribute financially towards the costs
incurred.
Pressuretorationandprioritisetreatmentswithin
the NHS is significant. The 1995 House of
Commons Health Committee report on priority
setting in the NHS stated that the NHS must
remain responsive to shifting public concerns
and debate. Bowling (1996) randomly sampled
theviewsoftheBritishpopulation. Outoftwelve
possible health priorities interviewees ranked
'treatments for children with life threatening
illnesses' first and 'treatment for infertility'
eleventh, just above 'treatment for people aged
75 and over with life threatening illnesses'.
However, when the public is asked, in isolation,
if infertility treatments should be funded by the
NHS their answeris different. Forexample, 84%
of medical students at Queen's University felt
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that infertile couples should not fund their own
infertilitytreatment. (Mooreetal, 1998)Caldwell
et al (1998) in another study reported similar
findings.
In dealing with the issue of infertility, there is,
amongst the community at large, a lack of
understanding of the associated stresses. Diana,
Princess ofWales famously remarked when she
was patron of 'Birthright', a research charity of
the Royal College of Obstetricians and
Gynaecologists, that"infertility wasnotadisease
and people should get on with their lives". In
Northern Ireland particularly, the situation is
further confounded by an active fundamentalist
religious lobby which sees assisted reproduction
as immoral.
In other areas of health service provision there
arenationallysetminimumnumbersoftreatments
purchased: no such requirements exist for
infertility. In a publication entitled "Effective
Health Care - the Management of Subfertility"
(University ofLeeds, 1992) it was proposed that
40 IVF treatment cycles should be purchased per
100,000 population. Taking the Northern Health
and Social Services Board as an example within
NorthernIreland, they shouldfund 160treatment
cycles per year for a population of400,000 Bull
and Lyons, (1994). Theyfund no cycles.
Currently, in Northern Ireland all assisted
reproduction treatments are provided at the
Regional Fertility Centre, Belfast. The cost, to a
couple, of a single cycle of IVF is £945.00 and
ICSI £1500.00. These are amongst the cheapest
prices in the United Kingdom. However, this
does not include the cost of drugs as, over the
years there has been a considerable amount of
good-will from general practitioners who have
written the necessary prescriptions. Where they
willnot, thecouplecanexpecttopayupto£1,000
extra.
In many other health service regions financial
provision is made for assisted reproduction,
resulting in a 'baby-by-postcode' scenario.
However, inthese areas fundingis often severely
limited. For example, couples over 35 years old
areoftenexcluded as arethosewhereoneorother
partneralreadyhasachild.Thissystemoffunding
is not equitable either. If there must be funding
restrictions, and this seems inevitable as there is
no area of medicine with unlimited funding,
perhaps it would be better if authorities decided
to spend an annual sum on the provision of